FDA Drug Topics: Reporting and Public Viewing of Individual Case Safety Reports (ICSRs) – May 24, 2022
FDA’s Division of Drug Information in the Center for Drug Evaluation and Research (CDER) is excited to present a series of educational webinars targeting the needs of all health care professionals and students, including physicians, physician assistants, nurses, pharmacists, and pharmacy technicians. Interact with FDA staff from a variety of divisions and learn more about the FDA and drug regulation!
On Tuesday, May 24, 2022, CDER's Office of Communication, Division of Drug Information (DDI) hosted a webinar titled: FDA Drug Topics: Reporting and Public Viewing of Individual Case Safety Reports (ICSRs). The purpose of this webinar was to understand the reporting of Individual Case Safety Reports (ICSRs) to FDA and learn how to access and view the publicly available data in the FDA Adverse Event Reporting System (FAERS). This session also focused on understanding data issues encountered in ICSRs and providing tips and methods to improve data quality.
View Presentation Here: https://youtu.be/zyyZ2_gnySE
Download Presentation Slides: Reporting and Public Viewing of Individual Case Safety Reports (ICSRs) (PDF - 2.73 MB)
Activity Outline and Continuing Education Information: Reporting and Public Viewing of Individual Case Safety Reports (ICSRs) (PDF - 94 KB)
If you have never attended an Adobe Connect meeting before:
Test your connection: Adobe Connect Diagnostic Test
Get a quick overview: Discover Adobe Connect Solutions
Adobe, the Adobe logo, Acrobat and Adobe Connect are either registered trademarks or trademarks of Adobe Systems Incorporated in the United States and/or other countries.
Resources For You